✦ LIBER ✦

The production of engineered nanoparticles to improve the delivery of pharmaceutical drugs

✍ Scribed by J Yun; W Glover; J-F Chen; H-K Chan

Book ID: 103849394
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 93 KB
Volume: 2
Category: Article
ISSN: 1549-9634
DOI: 10.1016/j.nano.2006.10.131

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nanoparticles for the delivery of genes

Nanoparticles for the delivery of genes and drugs to human hepatocytes

✍ Yamada, Tadanori; Iwasaki, Yasushi; Tada, Hiroko; Iwabuki, Hidehiko; Chuah, Mari 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 824 KB

PEGylated PLGA nanoparticles for the imp

PEGylated PLGA nanoparticles for the improved delivery of doxorubicin

✍ Jason Park; Peter M. Fong; Jing Lu; Kerry S. Russell; Carmen J. Booth; W. Mark S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 438 KB

ChemInform Abstract: Prodrug Approaches

ChemInform Abstract: Prodrug Approaches to the Improved Delivery of Peptide Drugs

✍ W. Wang; J. Jiang; C. E. Ballard; B. Wang 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 23 KB 👁 2 views

TAT-conjugated nanoparticles for the CNS

TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs

✍ Kavitha S. Rao; Maram K. Reddy; Jayme L. Horning; Vinod Labhasetwar 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 996 KB

Nanoparticles for Local Drug Delivery to

Nanoparticles for Local Drug Delivery to the Oral Mucosa: Proof of Principle Studies

✍ Andrew S. Holpuch; Garrett J. Hummel; Meng Tong; Garrett A. Seghi; Ping Pei; Pin 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 982 KB

The use of nanoparticle-mediated targete

The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance

✍ Yogesh B. Patil; Suresh K. Swaminathan; Tanmoy Sadhukha; Linan Ma; Jayanth Panya 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 805 KB

Overexpression of drug efflux transporters such as P-glycoprotein (P-gp) enables cancer cells to develop resistance to multiple anticancer drugs. Functional inhibitors of P-gp have shown promising efficacy in early clinical trials, but their long-term safety is yet to be established. A novel approac